Skip to main content

Table 1 Recommended prednisolone taper

From: A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol

Trial week

Prednisolone (mg/day)

0 (days 1–7)

20

1 (days 8–14)

20

2 (days 15–21)

15

3 (days 22–28)

15

4 (days 29–35)

15

5 (days 36–42)

10

6 (days 43–49)

10

7 (days 50–56)

10

8 (days 57–63)

5

9 (days 64–70)

5

10 (days 71–77)

5 every other day

11 (days 78–84)

5 every other day

12 (days 85–91)

0